Reviewing TriSalus Life Sciences (NASDAQ:TLSI) and Ayr Wellness (OTCMKTS:AYRWF)

TriSalus Life Sciences (NASDAQ:TLSI) and Ayr Wellness (OTCMKTS:AYRWF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

Insider & Institutional Ownership

2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 0.9% of Ayr Wellness shares are held by institutional investors. 16.3% of TriSalus Life Sciences shares are held by insiders. Comparatively, 8.1% of Ayr Wellness shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Volatility & Risk

TriSalus Life Sciences has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500. Comparatively, Ayr Wellness has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500.

Profitability

This table compares TriSalus Life Sciences and Ayr Wellness’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TriSalus Life Sciences	-60.85%	N/A	-69.91%
Ayr Wellness	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for TriSalus Life Sciences and Ayr Wellness, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TriSalus Life Sciences	1	1	2	0	2.25
Ayr Wellness	0	0	0	0	0.00

TriSalus Life Sciences presently has a consensus price target of $7.50, indicating a potential upside of 106.04%. Given TriSalus Life Sciences’ stronger consensus rating and higher probable upside, research analysts clearly believe TriSalus Life Sciences is more favorable than Ayr Wellness.

Valuation and Earnings

This table compares TriSalus Life Sciences and Ayr Wellness”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TriSalus Life Sciences	$45.15 million	4.95	-$39.23 million	($1.41)	-2.58
Ayr Wellness	$463.63 million	0.00	-$359.31 million	($2.67)	-0.01

TriSalus Life Sciences has higher earnings, but lower revenue than Ayr Wellness. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than Ayr Wellness, indicating that it is currently the more affordable of the two stocks.

Summary

TriSalus Life Sciences beats Ayr Wellness on 8 of the 13 factors compared between the two stocks.

About TriSalus Life Sciences

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

About Ayr Wellness

Ayr Wellness Inc. operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.